Bridgewater Bancshares, Inc. operates as the bank holding company for Bridgewater Bank that provides banking products and services to commercial real estate investors, entrepreneurs, business clients, and individuals in the United States. The company provides savings and money market accounts, demand deposits, time and brokered deposits, and interest and noninterest bearing transaction, as well as certificates of deposit. It offers commercial loans to sole proprietorships, partnerships, corporations, and other business enterprises to finance working capital, capital investment, or for other business related purposes; paycheck protection program loans; construction and land development loans; 1-4 family mortgage loans; multifamily lending products; owner and non-owner occupied commercial real estate loans; and consumer and other loans. In addition, the company online, mobile, and direct banking services. Bridgewater Bancshares, Inc. was incorporated in 2005 and is headquartered in Saint Louis Park, Minnesota.

Bridgewater Bancshares, Inc.

Here are five stocks added to the Zacks Rank #1 (Strong Buy) List today:
Phio Pharmaceuticals PHIO: This company which is focused on developing immuno-oncology therapeutics based on its proprietary self-delivering RNAi therapeutic platform, has seen the Zacks Consensus Estimate for its current year earnings increasing 14.4% over the last 60 days.
Phio Pharmaceuticals Corp. Price and Consensus
Phio Pharmaceuticals Corp. price-consensus-chart | Phio Pharmaceuticals Corp. Quote
Flex LNG FLNG: This shipping company which is focused on transportation of liquefied natural gas, has seen the Zacks Consensus Estimate for its current year earnings increasing 12.1% over the last 60 days.
Flex LNG Ltd. Price and Consensus
Flex LNG Ltd. price-consensus-chart | Flex LNG Ltd. Quote
Bridgewater Bancshares BWB: This bank holding company which provides personal and commercial banking products and services to commercial real estate investors, small business entrepreneurs and high-net-worth individuals, has seen the Zacks Consensus Estimate for its current year earnings increasing 11.7% over the last 60 days.
Bridgewater Bancshares, Inc. Price and Consensus
Bridgewater Bancshares, Inc. price-consensus-chart | Bridgewater Bancshares, Inc. Quote
Alerus Financial ALRS: This financial services company, which offers banking, retirement and benefit services, wealth management and mortgage to businesses and consumers, has seen the Zacks Consensus Estimate for its current year earnings increasing 6.1% over the last 60 day.
Alerus Financial Price and Consensus
Alerus Financial price-consensus-chart | Alerus Financial Quote
Halozyme Therapeutics HALO: This biopharmaceutical company which is focused on the development and commercialization of novel treatments for oncology indications by targeting tumor microenvironment, has seen the Zacks Consensus Estimate for its current year earnings increasing 4.4% over the last 60 days.
Halozyme Therapeutics, Inc. Price and Consensus
Halozyme Therapeutics, Inc. price-consensus-chart | Halozyme Therapeutics, Inc. Quote
You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
Only $1 to See All Zacks' Buys and Sells
We're not kidding.
Several years ago, we shocked our members by offering them 30-day access to all our picks for the total sum of only $1. No obligation to spend another cent.
Thousands have taken advantage of this opportunity. Thousands did not - they thought there must be a catch. Yes, we do have a reason. We want you to get acquainted with our portfolio services like Surprise Trader, Stocks Under $10, Technology Innovators,and more, that closed 256 positions with double- and triple-digit gains in 2024 alone.
See Stocks Now >>
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
Halozyme Therapeutics, Inc. (HALO) : Free Stock Analysis Report
Bridgewater Bancshares, Inc. (BWB) : Free Stock Analysis Report
Phio Pharmaceuticals Corp. (PHIO) : Free Stock Analysis Report
Flex LNG Ltd. (FLNG) : Free Stock Analysis Report
Alerus Financial (ALRS) : Free Stock Analysis Report
This article originally published on Zacks Investment Research (zacks.com).
Zacks Investment Research
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

New Strong Buy Stocks for May 28th

Although the recent 90-day pause in the U.S.-China trade conflict is cheering the market, it does not provide complete relief. The market will remain highly volatile without a comprehensive trade agreement and greater clarity on broader economic policy.
In this context, creating a curated portfolio of low-beta stocks is a prudent strategy. This provides a safeguard against the uncertain market, equipping investors to navigate volatility with greater resilience and foresight.
Hence, stocks like Bridgewater Bancshares, Inc. BWB, Stride Inc. LRN, 908 Devices Inc. MASS and Philip Morris International Inc. PM are worth betting on.
What Does Beta of a Stock Measure?
Beta measures the volatility or risk of a particular asset compared to the market. In other words, beta measures the extent of a security’s price movement relative to the market. In this article, we are considering the S&P 500 as the market.
If a stock has a beta of 1, then the price of the stock will move with the market. So, the stock is more volatile than the market if its beta is more than 1. In the same way, the stock is not as volatile as the market if its beta is less than 1.
For example, if the market offers a return of 20%, a stock with a beta of 3 will return 60%, which is overwhelming. Similarly, when the market slips 20%, the stock will sink 60%, which is devastating.
Screening Criteria Using Research Wizard:
We have taken a beta between 0 and 0.6 as our prime criterion for screening stocks that are less volatile than the market. However, this should not be the only factor to be considered while selecting a winning strategy. We need to take into account other parameters that can add value to the portfolio.
Percentage Change in Price in the Last 4 Weeks Greater Than Zero: This ensures that the stocks saw positive price movement over the last month.
Average 20-Day Volume Greater Than 50,000: A substantial trading volume ensures that the stocks are easily tradable.
Price Greater Than or Equal to $5: They must all be trading at a minimum of $5 or higher.
Zacks Rank Equal to 1: Zacks Rank #1 (Strong Buy) stocks indicate that they will significantly outperform the broader U.S. equity market over the next one to three months. You can see the complete list of today’s Zacks #1 Rank stocks here.
Here are four of the 18 stocks that qualified for the screening:
Bridgewater Bancshares
Attractive loan rates and well-managed deposit costs are helping Bridgewater Bancshares grow its lending and deposit businesses. Handsome loan demand, especially in affordable housing, is reflecting a lucrative business environment for Bridgewater Bancshares. Notably, the company is keeping problem loans low while managing risks carefully. Also, to reward shareholders, BWB is buying back its shares.
Stride
Stride maintains a stable business model by revolutionizing the educational experiences of individuals through the utilization of innovative, high-quality and technology-enabled educational solutions. LRN is well-positioned for long-term success, backed by increasing demand for school choice, innovative offerings, such as nationwide K–12 tutoring, and a focused growth strategy.
908 Devices
908 Devices is sharpening its focus by divesting a less profitable business and concentrating all its energy on handheld devices used in combating drug threats, chemical exposures and border security. Its sales are accelerating rapidly, with an increase in devices sold and the addition of new products, including those now utilized by governments in Europe. With more cash in hand, a robust product lineup and significant market opportunities ahead, it aims to achieve profitability soon and grow even faster by 2026.
Philip Morris
From a traditional cigarette company, Philip Morris is gradually transforming into a smoke-free player as represented by IQOS heated tobacco and ZYN nicotine pouches that are gradually becoming the company’s major focus area. Philip Morris is also strongly focused on rewarding shareholders and on cost cutting initiatives.
You can get the rest of the stocks on this list by signing up now for your two-week free trial to the Research Wizard and start using this screen in your own trading. Further, you can also create your own strategies and test them first before taking the investment plunge.
The Research Wizard is a great place to begin. It's easy to use. Everything is in plain language. And it's very intuitive. Start your Research Wizard trial today. And the next time you read an economic report, open up the Research Wizard, plug your finds in, and see what gems come out.
Click here to sign up for a free trial to the Research Wizard today.
Disclosure: Officers, directors and/or employees of Zacks Investment Research may own or have sold short securities and/or hold long and/or short positions in options that are mentioned in this material. An affiliated investment advisory firm may own or have sold short securities and/or hold long and/or short positions in options that are mentioned in this material.
Disclosure: Performance information for Zacks’ portfolios and strategies are available at: https://www.zacks.com/performance.
Only $1 to See All Zacks' Buys and Sells
We're not kidding.
Several years ago, we shocked our members by offering them 30-day access to all our picks for the total sum of only $1. No obligation to spend another cent.
Thousands have taken advantage of this opportunity. Thousands did not - they thought there must be a catch. Yes, we do have a reason. We want you to get acquainted with our portfolio services like Surprise Trader, Stocks Under $10, Technology Innovators,and more, that closed 256 positions with double- and triple-digit gains in 2024 alone.
See Stocks Now >>
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
Philip Morris International Inc. (PM) : Free Stock Analysis Report
Stride, Inc. (LRN) : Free Stock Analysis Report
Bridgewater Bancshares, Inc. (BWB) : Free Stock Analysis Report
This article originally published on Zacks Investment Research (zacks.com).
Zacks Investment Research
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

Bet On 4 Low-Beta Stocks BWB, LRN, MASS & PM Despite Tariff Truce

The following are today's upgrades for Validea's Small-Cap Growth Investor model based on the published strategy of Motley Fool. This strategy looks for small cap growth stocks with solid fundamentals and strong price performance.
BRIDGEWATER BANCSHARES INC (BWB) is a small-cap value stock in the Money Center Banks industry. The rating according to our strategy based on Motley Fool changed from 73% to 80% based on the firm’s underlying fundamentals and the stock’s valuation. A score of 80% or above typically indicates that the strategy has some interest in the stock and a score above 90% typically indicates strong interest.
Company Description: Bridgewater Bancshares, Inc. is a financial holding company with one wholly owned subsidiary, Bridgewater Bank (the Bank). The Bank focuses primarily on commercial lending, consisting of loans secured by nonfarm, nonresidential properties, loans secured by multifamily residential properties, nonowner occupied single family residential properties, construction loans, land development loans and commercial and industrial loans. The Bank offers loan and deposit products primarily for commercial clients. The Bank also offers consumers traditional retail deposit products through its branch network, along with online, mobile, and direct banking channels. The Bank has developed a suite of deposit products targeted at commercial clients, including a variety of remote deposit and cash management products, along with commercial transaction accounts. The Bank has nine full-service offices located in Bloomington, Greenwood, Minneapolis (two), St. Louis Park, Orono, and St. Paul, Minnesota.
The following table summarizes whether the stock meets each of this strategy's tests. Not all criteria in the below table receive equal weighting or are independent, but the table provides a brief overview of the strong and weak points of the security in the context of the strategy's criteria.
PROFIT MARGIN:
PASS
RELATIVE STRENGTH:
FAIL
COMPARE SALES AND EPS GROWTH TO THE SAME PERIOD LAST YEAR:
PASS
INSIDER HOLDINGS:
PASS
CASH FLOW FROM OPERATIONS:
PASS
PROFIT MARGIN CONSISTENCY:
FAIL
R&D AS A PERCENTAGE OF SALES:
NEUTRAL
CASH AND CASH EQUIVALENTS:
PASS
"THE FOOL RATIO" (P/E TO GROWTH):
FAIL
AVERAGE SHARES OUTSTANDING:
PASS
SALES:
PASS
DAILY DOLLAR VOLUME:
PASS
PRICE:
PASS
INCOME TAX PERCENTAGE:
PASS
Detailed Analysis of BRIDGEWATER BANCSHARES INC
BWB Guru Analysis
BWB Fundamental Analysis
HCI GROUP INC (HCI) is a small-cap value stock in the Insurance (Prop. & Casualty) industry. The rating according to our strategy based on Motley Fool changed from 69% to 83% based on the firm’s underlying fundamentals and the stock’s valuation. A score of 80% or above typically indicates that the strategy has some interest in the stock and a score above 90% typically indicates strong interest.
Company Description: HCI Group, Inc. is a holding company engaged in property and casualty insurance, information technology services, insurance management, real estate and reinsurance. It operates through two operating units. The first unit includes four insurance companies, a captive reinsurance company, and operations in claims management and real estate. The second unit, called Exzeo Group, Inc., is engaged in insurance technology that utilizes advanced underwriting algorithms and data analytics. Exzeo helps property and casualty insurers to transform underwriting outcomes. Its insurance business includes property and casualty insurance division and reinsurance operations, excluding the insurance operations under reciprocal exchange operations. The reciprocal exchange business includes insurance operations of CORE and Tailrow, consolidated VIEs. The real estate operations business includes companies engaged in operating commercial properties for investment purposes or for use in its own operations.
The following table summarizes whether the stock meets each of this strategy's tests. Not all criteria in the below table receive equal weighting or are independent, but the table provides a brief overview of the strong and weak points of the security in the context of the strategy's criteria.
PROFIT MARGIN:
PASS
RELATIVE STRENGTH:
FAIL
COMPARE SALES AND EPS GROWTH TO THE SAME PERIOD LAST YEAR:
FAIL
INSIDER HOLDINGS:
PASS
CASH FLOW FROM OPERATIONS:
PASS
PROFIT MARGIN CONSISTENCY:
PASS
R&D AS A PERCENTAGE OF SALES:
NEUTRAL
CASH AND CASH EQUIVALENTS:
PASS
ACCOUNTS RECEIVABLE TO SALES:
PASS
"THE FOOL RATIO" (P/E TO GROWTH):
PASS
AVERAGE SHARES OUTSTANDING:
PASS
SALES:
FAIL
DAILY DOLLAR VOLUME:
PASS
PRICE:
PASS
INCOME TAX PERCENTAGE:
PASS
Detailed Analysis of HCI GROUP INC
HCI Guru Analysis
HCI Fundamental Analysis
SEMLER SCIENTIFIC INC (SMLR) is a small-cap value stock in the Medical Equipment & Supplies industry. The rating according to our strategy based on Motley Fool changed from 69% to 83% based on the firm’s underlying fundamentals and the stock’s valuation. A score of 80% or above typically indicates that the strategy has some interest in the stock and a score above 90% typically indicates strong interest.
Company Description: Semler Scientific, Inc. is engaged in developing and marketing technology products and services to healthcare providers to combat chronic diseases. The Company's flagship product, QuantaFlo, which is patented and cleared by the United States Food and Drug Administration (FDA), is a rapid point-of-care test that measures arterial blood flow in the extremities. The QuantaFlo test aids in the diagnosis of cardiovascular diseases, such as peripheral arterial disease (PAD), and the Company is seeking a new 510(k) clearance for expanded-indications. QuantaFlo is used by healthcare providers to evaluate their patient's risk of mortality and major adverse cardiovascular events (MACE). QuantaFlo features a sensor clamp that is placed on the toe or finger. A blood flow waveform is instantaneously constructed by its software algorithm. The Company delivers QuantaFlo directly to its customers. The Company also invests in bitcoin and has adopted Bitcoin as its primary treasury asset.
The following table summarizes whether the stock meets each of this strategy's tests. Not all criteria in the below table receive equal weighting or are independent, but the table provides a brief overview of the strong and weak points of the security in the context of the strategy's criteria.
PROFIT MARGIN:
PASS
RELATIVE STRENGTH:
FAIL
COMPARE SALES AND EPS GROWTH TO THE SAME PERIOD LAST YEAR:
FAIL
INSIDER HOLDINGS:
PASS
CASH FLOW FROM OPERATIONS:
PASS
PROFIT MARGIN CONSISTENCY:
PASS
R&D AS A PERCENTAGE OF SALES:
NEUTRAL
CASH AND CASH EQUIVALENTS:
PASS
INVENTORY TO SALES:
PASS
ACCOUNTS RECEIVABLE TO SALES:
PASS
LONG TERM DEBT/EQUITY RATIO:
PASS
"THE FOOL RATIO" (P/E TO GROWTH):
PASS
AVERAGE SHARES OUTSTANDING:
PASS
SALES:
PASS
DAILY DOLLAR VOLUME:
PASS
PRICE:
PASS
INCOME TAX PERCENTAGE:
FAIL
Detailed Analysis of SEMLER SCIENTIFIC INC
SMLR Guru Analysis
SMLR Fundamental Analysis
Motley Fool Portfolio
About Motley Fool: Brothers David and Tom Gardner often wear funny hats in public appearances, but they're hardly fools -- at least not the kind whose advice you should readily dismiss. The Gardners are the founders of the popular Motley Fool web site, which offers frank and often irreverent commentary on investing, the stock market, and personal finance. The Gardners' "Fool" really is a multi-media endeavor, offering not only its web content but also several books written by the brothers, a weekly syndicated newspaper column, and subscription newsletter services.
About Validea: Validea is aninvestment researchservice that follows the published strategies of investment legends. Validea offers both stock analysis and model portfolios based on gurus who have outperformed the market over the long-term, including Warren Buffett, Benjamin Graham, Peter Lynch and Martin Zweig. For more information about Validea, click here
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

Validea Motley Fool Strategy Daily Upgrade Report - 4/26/2025

On 2/14/25, Bridgewater Bancshares Inc's 5.875% Dep Shares Non Cumul Preferred Stock Ser A (Symbol: BWBBP) will trade ex-dividend, for its quarterly dividend of $0.3672, payable on 3/4/25. As a percentage of BWBBP's recent share price of $20.00, this dividend works out to approximately 1.84%, so look for shares of BWBBP to trade 1.84% lower — all else being equal — when BWBBP shares open for trading on 2/14/25. On an annualized basis, the current yield is approximately 7.34%, which compares to an average yield of 7.52% in the "Banking & Savings" preferred stock category, according to Preferred Stock Channel. The chart below shows the one year performance of BWBBP shares, versus BWB:
Below is a dividend history chart for BWBBP, showing historical dividends prior to the most recent $0.3672 on Bridgewater Bancshares Inc's 5.875% Dep Shares Non Cumul Preferred Stock Ser A:
In Wednesday trading, Bridgewater Bancshares Inc's 5.875% Dep Shares Non Cumul Preferred Stock Ser A (Symbol: BWBBP) is currently up about 1.5% on the day, while the common shares (Symbol: BWB) are off about 2.2%.
Click here to learn which S.A.F.E. dividend stocks also have preferred shares that should be on your radar screen »
Also see:
Top Stocks Held By Ken Griffin
DPHC YTD Return
BAC Technical Analysis
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

Bridgewater Bancshares Preferred Stock About To Put More Money In Your Pocket

For Immediate Release
Chicago, IL – February 7, 2025 – Stocks in this week’s article are — Bridgewater Bancshares, Inc. BWB, Eastern Bankshares, Inc. EBC and BrainsWay Ltd. BWAY.
3 Top-Ranked Breakout Stocks to Buy Now: BWB, EBC, BWAY
Searching for breakout stocks within a specific price band is an active investing strategy. Consider selling if the price falls below the lower band and holding for gains if it exceeds the upper band when choosing breakout stocks.
To that end, Bridgewater Bancshares, Inc., Eastern Bankshares, Inc. and BrainsWay Ltd. have been selected as the breakout stocks for today.
Zeroing-In on Breakout Stocks
To pick a breakout stock, calculate support and resistance levels. A support level is the lower bound for stock movements, while a resistance level refers to the maximum price it trades at within a considerable period.
In other words, the demand for a stock is at its lowest at its support level, which means that most traders are willing to sell it. Most traders are willing to go long on the stock at the resistance level, meaning they would like to add them to their portfolio. The key to identifying breakout stocks is to zero in on those on the verge of a breakout or those that have just broken above the resistance level.
Has a Genuine Breakout Occurred?
The primary risk associated with such a strategy is that the decision to buy an apparent breakout candidate has been incorrectly timed. When a stock moves above the resistance level, it should be a highly prized commodity for traders. However, whether such a breakout is genuine is another matter altogether.
For a bona fide breakout, the stock’s earlier resistance barrier should become its new support level. This only happens if the trading channel that has been established is tested by observing long-term price trends. The strength of the support and resistance levels can be ascertained only through such a study. Despite the risk of misidentification, correctly identifying such stocks can yield considerable returns, even at a price that may not seem attractive at first glance.
These criteria narrow the universe of more than 6,853 stocks to only nine. Here are the top three stocks:
Bridgewater Bancshares
Bridgewater Bancshares offers banking services to various clients in the United States, including real estate investors and entrepreneurs. BWB has an expected earnings growth rate of 31.4% for the current year.
Eastern Bankshares
Eastern Bankshares offers banking products and services to retail, commercial, and small business customers. EBC has an expected earnings growth rate of 40.6% for the current year.
BrainsWay
BrainsWay develops and sells noninvasive neurostimulation treatments for mental health disorders globally. BWAY has an expected earnings growth rate of 130.8% for the current year.
You can get the rest of the stocks on this list by signing up now for your 2-week free trial to the Research Wizard and start using this screen in your own trading. Further, you can also create your own strategies and test them first before taking the investment plunge.
The Research Wizard is a great place to begin. It's easy to use. Everything is in plain language. And it's very intuitive. Start your Research Wizard trial today. And the next time you read an economic report, open up the Research Wizard, plug your finds in, and see what gems come out.
Click here to sign up for a free trial to the Research Wizard today.
For the rest of this Screen of the Week article please visit Zacks.com at: https://www.zacks.com/stock/news/2410748/3-top-ranked-breakout-stocks-to-buy-now-bwb-ebc-bway?art_rec=quote-stock_overview-zacks_news-ID01-txt-2410748
Zacks Investment Research is under common control with affiliated entities (including a broker-dealer and an investment adviser), which may engage in transactions involving the foregoing securities for the clients of such affiliates.
Contact: Jim Giaquinto
Company: Zacks.com
Phone: 312-265-9268
Email: pr@zacks.com
Visit: https://www.zacks.com/
Zacks.com provides investment resources and informs you of these resources, which you may choose to use in making your own investment decisions. Zacks is providing information on this resource to you subject to the Zacks "Terms and Conditions of Service" disclaimer. www.zacks.com/disclaimer.
Past performance is no guarantee of future results. Inherent in any investment is the potential for loss. This material is being provided for informational purposes only and nothing herein constitutes investment, legal, accounting or tax advice, or a recommendation to buy, sell or hold a security. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. It should not be assumed that any investments in securities, companies, sectors or markets identified and described were or will be profitable. All information is current as of the date of herein and is subject to change without notice. Any views or opinions expressed may not reflect those of the firm as a whole. Zacks Investment Research does not engage in investment banking, market making or asset management activities of any securities. These returns are from hypothetical portfolios consisting of stocks with Zacks Rank = 1 that were rebalanced monthly with zero transaction costs. These are not the returns of actual portfolios of stocks. The S&P 500 is an unmanaged index. Visit https://www.zacks.com/performance for information about the performance numbers displayed in this press release.
Free Today: Profiting from The Future’s Brightest Energy Source
The demand for electricity is growing exponentially. At the same time, we’re working to reduce our dependence on fossil fuels like oil and natural gas. Nuclear energy is an ideal replacement.
Leaders from the US and 21 other countries recently committed to TRIPLING the world’s nuclear energy capacities. This aggressive transition could mean tremendous profits for nuclear-related stocks – and investors who get in on the action early enough.
Our urgent report, Atomic Opportunity: Nuclear Energy's Comeback, explores the key players and technologies driving this opportunity, including 3 standout stocks poised to benefit the most.
Download Atomic Opportunity: Nuclear Energy's Comeback free today.
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
Bridgewater Bancshares, Inc. (BWB) : Free Stock Analysis Report
Brainsway Ltd. Sponsored ADR (BWAY) : Free Stock Analysis Report
Eastern Bankshares, Inc. (EBC) : Free Stock Analysis Report
To read this article on Zacks.com click here.
Zacks Investment Research
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

Zacks.com featured highlights include Bridgewater Bancshares, Eastern Bankshares and BrainsWay

On 11/15/24, Bridgewater Bancshares Inc's 5.875% Dep Shares Non Cumul Preferred Stock Ser A (Symbol: BWBBP) will trade ex-dividend, for its quarterly dividend of $0.3672, payable on 12/2/24. As a percentage of BWBBP's recent share price of $19.45, this dividend works out to approximately 1.89%, so look for shares of BWBBP to trade 1.89% lower — all else being equal — when BWBBP shares open for trading on 11/15/24. On an annualized basis, the current yield is approximately 7.55%, which compares to an average yield of 7.84% in the "Credit Services & Lending" preferred stock category, according to Preferred Stock Channel. The chart below shows the one year performance of BWBBP shares, versus BWB:
Below is a dividend history chart for BWBBP, showing historical dividends prior to the most recent $0.3672 on Bridgewater Bancshares Inc's 5.875% Dep Shares Non Cumul Preferred Stock Ser A:
In Wednesday trading, Bridgewater Bancshares Inc's 5.875% Dep Shares Non Cumul Preferred Stock Ser A (Symbol: BWBBP) is currently down about 3% on the day, while the common shares (Symbol: BWB) are up about 0.5%.
Click here to learn which S.A.F.E. dividend stocks also have preferred shares that should be on your radar screen »
Also see:
ACEL Average Annual Return
IMUX shares outstanding history
Funds Holding BRHY
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

ridgewater Bancshares Preferred Stock Series A About To Put More Money In Your Pocket

Middlefield Banc Corp. (MBCN) came out with quarterly earnings of $0.29 per share, missing the Zacks Consensus Estimate of $0.47 per share. This compares to earnings of $0.47 per share a year ago. These figures are adjusted for non-recurring items.
This quarterly report represents an earnings surprise of -38.30%. A quarter ago, it was expected that this company would post earnings of $0.42 per share when it actually produced earnings of $0.52, delivering a surprise of 23.81%.
Over the last four quarters, the company has surpassed consensus EPS estimates two times.
Middlefield Banc, which belongs to the Zacks Banks - Northeast industry, posted revenues of $16.82 million for the quarter ended September 2024, missing the Zacks Consensus Estimate by 1.66%. This compares to year-ago revenues of $17.78 million. The company has topped consensus revenue estimates just once over the last four quarters.
The sustainability of the stock's immediate price movement based on the recently-released numbers and future earnings expectations will mostly depend on management's commentary on the earnings call.
Middlefield Banc shares have lost about 6.1% since the beginning of the year versus the S&P 500's gain of 22.5%.
What's Next for Middlefield Banc?
While Middlefield Banc has underperformed the market so far this year, the question that comes to investors' minds is: what's next for the stock?
There are no easy answers to this key question, but one reliable measure that can help investors address this is the company's earnings outlook. Not only does this include current consensus earnings expectations for the coming quarter(s), but also how these expectations have changed lately.
Empirical research shows a strong correlation between near-term stock movements and trends in earnings estimate revisions. Investors can track such revisions by themselves or rely on a tried-and-tested rating tool like the Zacks Rank, which has an impressive track record of harnessing the power of earnings estimate revisions.
Ahead of this earnings release, the estimate revisions trend for Middlefield Banc: favorable. While the magnitude and direction of estimate revisions could change following the company's just-released earnings report, the current status translates into a Zacks Rank #1 (Strong Buy) for the stock. So, the shares are expected to outperform the market in the near future. You can see the complete list of today's Zacks #1 Rank (Strong Buy) stocks here.
It will be interesting to see how estimates for the coming quarters and current fiscal year change in the days ahead. The current consensus EPS estimate is $0.46 on $17.05 million in revenues for the coming quarter and $1.96 on $68 million in revenues for the current fiscal year.
Investors should be mindful of the fact that the outlook for the industry can have a material impact on the performance of the stock as well. In terms of the Zacks Industry Rank, Banks - Northeast is currently in the top 38% of the 250 plus Zacks industries. Our research shows that the top 50% of the Zacks-ranked industries outperform the bottom 50% by a factor of more than 2 to 1.
One other stock from the same industry, Bridgewater (BWB), is yet to report results for the quarter ended September 2024. The results are expected to be released on October 23.
This company is expected to post quarterly earnings of $0.25 per share in its upcoming report, which represents a year-over-year change of -16.7%. The consensus EPS estimate for the quarter has remained unchanged over the last 30 days.
Bridgewater's revenues are expected to be $27.1 million, down 0.2% from the year-ago quarter.
Only $1 to See All Zacks' Buys and Sells
We're not kidding.
Several years ago, we shocked our members by offering them 30-day access to all our picks for the total sum of only $1. No obligation to spend another cent.
Thousands have taken advantage of this opportunity. Thousands did not - they thought there must be a catch. Yes, we do have a reason. We want you to get acquainted with our portfolio services like Surprise Trader, Stocks Under $10, Technology Innovators,and more, that closed 228 positions with double- and triple-digit gains in 2023 alone.
See Stocks Now >>
Want the latest recommendations from Zacks Investment Research? Today, you can download 5 Stocks Set to Double. Click to get this free report
Middlefield Banc Corp. (MBCN) : Free Stock Analysis Report
Bridgewater Bancshares, Inc. (BWB) : Free Stock Analysis Report
To read this article on Zacks.com click here.
Zacks Investment Research
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

Middlefield Banc Corp. (MBCN) Lags Q3 Earnings and Revenue Estimates

On 8/15/24, Bridgewater Bancshares Inc's 5.875% Dep Shares Non Cumul Preferred Stock Ser A (Symbol: BWBBP) will trade ex-dividend, for its quarterly dividend of $0.3672, payable on 9/3/24. As a percentage of BWBBP's recent share price of $18.75, this dividend works out to approximately 1.96%, so look for shares of BWBBP to trade 1.96% lower — all else being equal — when BWBBP shares open for trading on 8/15/24. On an annualized basis, the current yield is approximately 7.83%, which compares to an average yield of 8.09% in the "Credit Services & Lending" preferred stock category, according to Preferred Stock Channel. The chart below shows the one year performance of BWBBP shares, versus BWB:
Below is a dividend history chart for BWBBP, showing historical dividends prior to the most recent $0.3672 on Bridgewater Bancshares Inc's 5.875% Dep Shares Non Cumul Preferred Stock Ser A:
In Tuesday trading, Bridgewater Bancshares Inc's 5.875% Dep Shares Non Cumul Preferred Stock Ser A (Symbol: BWBBP) is currently trading flat on the day, while the common shares (Symbol: BWB) are up about 0.6%.
Click here to learn which S.A.F.E. dividend stocks also have preferred shares that should be on your radar screen »
Also see:
Cheapest Stocks Right Now
STIM Average Annual Return
WFRD Stock Predictions
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

Bridgewater Bancshares Preferred Stock Series A Goes Ex-Dividend Soon

In trading on Friday, shares of Bridgewater Bancshares Inc's 5.875% Dep Shares Non Cumul Preferred Stock Ser A (Symbol: BWBBP) were yielding above the 8% mark based on its quarterly dividend (annualized to $1.4688), with shares changing hands as low as $17.11 on the day. This compares to an average yield of 8.28% in the "Credit Services & Lending" preferred stock category, according to Preferred Stock Channel. As of last close, BWBBP was trading at a 26.28% discount to its liquidation preference amount, versus the average discount of 18.74% in the "Credit Services & Lending" category. Investors should keep in mind that the shares are not cumulative, meaning that in the event of a missed payment, the company does not have to pay the balance of missed dividends to preferred shareholders before resuming a common dividend.
Below is a dividend history chart for BWBBP, showing historical dividend payments on Bridgewater Bancshares Inc's 5.875% Dep Shares Non Cumul Preferred Stock Ser A:
In Friday trading, Bridgewater Bancshares Inc's 5.875% Dep Shares Non Cumul Preferred Stock Ser A (Symbol: BWBBP) is currently down about 0.9% on the day, while the common shares (Symbol: BWB) are up about 1.1%.
Also see:
Top Stocks Held By Chase Coleman
SVV Insider Buying
Funds Holding SPUS
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

Bridgewater Bancshares Preferred Stock Shares Cross 8% Yield Mark

On 2/14/24, Bridgewater Bancshares Inc's 5.875% Dep Shares Non Cumul Preferred Stock Ser A (Symbol: BWBBP) will trade ex-dividend, for its quarterly dividend of $0.3672, payable on 3/1/24. As a percentage of BWBBP's recent share price of $18.96, this dividend works out to approximately 1.94%, so look for shares of BWBBP to trade 1.94% lower — all else being equal — when BWBBP shares open for trading on 2/14/24. On an annualized basis, the current yield is approximately 7.81%, which compares to an average yield of 8.26% in the "Credit Services & Lending" preferred stock category, according to Preferred Stock Channel. The chart below shows the one year performance of BWBBP shares, versus BWB:
Below is a dividend history chart for BWBBP, showing historical dividends prior to the most recent $0.3672 on Bridgewater Bancshares Inc's 5.875% Dep Shares Non Cumul Preferred Stock Ser A:
Free Report: Top 8%+ Dividends (paid monthly)
In Monday trading, Bridgewater Bancshares Inc's 5.875% Dep Shares Non Cumul Preferred Stock Ser A (Symbol: BWBBP) is currently up about 0.8% on the day, while the common shares (Symbol: BWB) are up about 2%.
Click here to learn which S.A.F.E. dividend stocks also have preferred shares that should be on your radar screen »
Also see:
Institutional Holders of KOG
LVB Videos
Funds Holding MVBF
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

Indicator	TTM Median
P/E	13.91 13.37
Price/Sales	1.76 1.92
P/B	0.94 1.10
P/FCF	17.27 10.25

Indicator	TTM Median
ROE	7.23 10.06
ROA	0.67 1.13
ROI	3.82 6.38
Net Worth	0.42 0.99
Quick Ratio	0.00 1.40
Current Ratio	1.02 0.96

Indicator	TTM Median
Net Profit Margin	12.81 15.86
Operating Margin	18.18 21.72
Gross Margin	44.21 68.17
Return on tangible equity	7.28 12.03

Indicator	TTM Median
EPS	0.27 0.60
EPS Forecast	0.25 0.61
Revenue	63.00M 85.50M
Gross Profit	27.00M —
EBITDA	0.00 —

Bridgewater Bancshares, Inc.

Fundamental BWB

Valuation

Debts

Efficiency

Other ratios

Revenue